Barclays lowered the firm’s price target on Zscaler to $135 from $143 and keeps an Equal Weight rating on the shares. The company’s billings grew 34% year-over-year in fiscal Q2, which digested two points of headwind from more ramp deals but also benefited from longer duration than expected, the analyst tells investors in a research note. The firm says this is the second quarter of deceleration, which reflects the different macro, but will also create more debate on competition.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ZS: